Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $5.7 million.

  • iSpecimen's Total Current Liabilities fell 9.09% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 9.09%. This contributed to the annual value of $5.8 million for FY2024, which is 4.60% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Total Current Liabilities is $5.7 million, which was up 10.18% from $5.2 million recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Total Current Liabilities peaked at $6.3 million during Q3 2024, and registered a low of $2.0 million during Q2 2022.
  • In the last 3 years, iSpecimen's Total Current Liabilities had a median value of $5.7 million in 2025 and averaged $5.1 million.
  • As far as peak fluctuations go, iSpecimen's Total Current Liabilities tumbled by 88.68% in 2021, and later spiked by 103.25% in 2024.
  • Quarterly analysis of 5 years shows iSpecimen's Total Current Liabilities stood at $2.5 million in 2021, then surged by 70.87% to $4.3 million in 2022, then surged by 41.29% to $6.0 million in 2023, then dropped by 4.60% to $5.8 million in 2024, then fell by 9.09% to $5.7 million in 2025.
  • Its Total Current Liabilities stands at $5.7 million for Q3 2025, versus $5.2 million for Q2 2025 and $4.9 million for Q1 2025.